Nektar Therapeutics Undistributed Earnings of Foreign Subsidiaries
Nektar Therapeutics (NKTR) had Undistributed Earnings of Foreign Subsidiaries of $3.40 million as of 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Notes › Income Taxes
us-gaap:UndistributedEarningsOfForeignSubsidiaries · last filed 2017-03-01
- 2016-12-31: Undistributed Earnings of Foreign Subsidiaries $3.40M.
- 2015-12-31: Undistributed Earnings of Foreign Subsidiaries $4.40M.
- 2014-12-31: Undistributed Earnings of Foreign Subsidiaries $3.90M.
- 2013-12-31: Undistributed Earnings of Foreign Subsidiaries $1.70M.
| Period end | Undistributed Earnings of Foreign Subsidiaries |
|---|---|
| 2016-12-31 | $3.40M 10-K · filed 2017-03-01 |
| 2015-12-31 | $4.40M 10-K · filed 2016-02-29 |
| 2014-12-31 | $3.90M 10-K · filed 2015-02-26 |
| 2013-12-31 | $1.70M 10-K · filed 2014-02-27 |
| 2012-12-31 | $3.10M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |